Kenneth Gollob is Director of the Center for Research in Immuno-oncology (CRIO) and Head of the Translational Immuno-oncology Laboratory at the Hospital Israelita Albert Einstein in Sao Paulo, Brazil. His patient centric research uses multi-omics approaches to elucidate immune mechanisms behind response to therapy, as well as discover clinically useful biomarkers and identification of novel immunotherapy targets for cancer treatment. He obtained his Ph.D. in Immunology from the University of Colorado Medical Center and National Jewish Center for Immunology.  He performed his postdoctoral fellowship at DNAX Research Institute, and was a Visiting Associate Professor at Stanford University, and a visiting scientist at the NIH-National Cancer Institute.